Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan treatment in stiff skin syndrome
NL-OMON36060Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of losartan in stiff skin syndrome (SSS) and Congenital Morphea, sponsored by Leiden University Medical Center. Primary endpoints: Improvement of joint excursions, Improvement of skin hardening and 2 more. Started Sep 2011; status: active, not recruiting.
02
Drugs
losartan
03
Conditions
stiff skin syndrome (SSS)Congenital Morphea
Beyond the preview
Go deeper on NL-OMON36060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36060.